By moving beyond symptom management and targeting the root causesblood flow, inflammation, and the Innate Repair Receptorwe are finally giving the body the tools it needs to rewire itself
CrossRef Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis Jung Hoon Cha, Na Ri Park, Sung Woo Cho, Heechul Nam, Hyun Yang, Eun Sun Jung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung, Si Hyun Bae Frontiers in Immunology .2024;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response Camilo Julio Llamoza-Torres, Mara Fuentes-Pardo, Bruno Ramos-Molina Metabolism and Target Organ Damage .2024;[Epub] CrossRef Biological and clinical role of TREM2 in liver diseases Ke Ma, Shouliang Guo, Jin Li, Tao Wei, Tingbo Liang Hepatology Communications .2024;[Epub] CrossRef 12,157 View 374 Download 15 Web of Science Crossref Special Review Steatotic liver disease Abstract PDF The existing term non-alcoholic fatty liver disease (NAFLD) has raised substantial concerns due to its inherent disadvantages of using exclusionary diagnostic criteria and the stigmatizing word fatty. Three pan-national liver associations set out to explore a new nomenclature to replace both NAFLD and its suggested alternative, metabolic (dysfunction)-associated fatty liver disease (MAFLD)
In the study by Kim et al., agmatine sulfate (25, 50, and 100 mg/kg) or saline was supplemented in the VPA model via intraperitoneal injection 30 min before each behavior test ( Naringenin Naringenin (5,7-Dihydroxy-2-(4-hydroxy phenyl) chroman-4-one) is a flavanone abundantly found in grapefruit, orange, and tomato peels (74)
The process of reconstitution involves adding a sterile diluent, most commonly bacteriostatic water, to dissolve the peptide powder and create a usable solution
